Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179426 · ClinicalTrials.gov registry record
Effect of Antiseizure Medication on Hormone Levels and Sexual Function in Men With Epilepsy
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 175
- Enrollment target
NCT00179426: Completed study, sponsored by Beth Israel Deaconess Medical Center.
NCT00179426 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 175 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00179426 has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 175 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if antiseizure drugs affect hormone levels and sexual function in men with seizures.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 1999-10 |
| Est. Completion | 2006-06 |
What the finished NCT00179426 record still lists
NCT00179426 is an observational study that tracks outcomes without assigning an intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00179426 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00179426 about?
NCT00179426 is a clinical study titled "Effect of Antiseizure Medication on Hormone Levels and Sexual Function in Men With Epilepsy". The purpose of this study is to determine if antiseizure drugs affect hormone levels and sexual function in men with seizures.
What is the current status of trial NCT00179426?
This trial is currently completed. The enrollment target is 175 participants. The study started on 1999-10. Estimated completion is 2006-06.
Who is sponsoring clinical trial NCT00179426?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04722341 · 175 participants · NA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
- NCT05094037 · 175 participants · NA
Orthotic Treatment of Diabetic Foot Ulcers
- NCT05165745 · 175 participants · NA
Stick2PrEP Cisgender Women and Trans Individuals
- NCT05312255 · 175 participants · NA
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia